ABVC vs ECL
ABVC Biopharma Inc (ABVC) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
ABVC Biopharma Inc (ABVC) is a biotechnology company listed on NASDAQ.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported ABVC revenue for 2024-12-31 was $509.6K. Net income was -$5.3M. Revenue was up 234.3% from 2023-12-31 to 2024-12-31. ABVC currently screens at market cap $35.9M.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
ABVC currently screens at market cap $35.9M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the ABVC and ECL stock pages for the full models.
Not investment advice.